Abbonarsi

Surgical rather than endoscopic resection of early-stage colorectal cancers promotes excessive imaging surveillance - 11/11/21

Doi : 10.1016/j.clinre.2021.101735 
Martin Bordet a, Jean-François Bretagne b, , Christine Piette c, Chloé Rousseau d, Thomas Grainville a, Mathilde Cosson c, Astrid Lièvre a, b, c, e
a Department of Gastroenterology, University Hospital, 35033 Rennes, France 
b Rennes 1 University, 35000 Rennes, France 
c ADECI 35 (Association pour le Dépistage des Cancers en Ille-et-Vilaine), 35040 Rennes, France 
d Department of Biostatistics, University Hospital, 35033 Rennes, France 
e COSS (Chemistry Oncogenesis Stress Signaling), UMR_S 1242, Rennes, France 

Corresponding author.

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

pagine 9
Iconografia 0
Video 0
Altro 0

Highlights

Little is known about the use of imaging surveillance after curative resection of early-stage colorectal cancer.
Imaging surveillance was analyzed in a cohort of 450 patients with screening-detected stage 0 or stage 1 colorectal cancers.
Imaging surveillance was performed for 159 (35.3%) patients, more often for those with stage 1 (66.5%) than stage 0 (14.2%) tumours.
Factors associated with imaging monitoring were the gastroenterologist assigned to the patient and surgical vs endoscopic resection.
This study highlights the abusive and paradoxical nature of imaging surveillance in patients undergoing surgery.

Il testo completo di questo articolo è disponibile in PDF.

Abstract

Background and aims

: Imaging surveillance after curative resection of colorectal cancer (CRC) is debated, particularly in cases of early-stage CRC. The aim of this study was to retrospectively analyze whether and how patients with screened stage 0 and stage 1 CRC were monitored by imaging.

Methods

A cohort of patients with stage 0 (intramucosal) or stage 1 (T1N0) CRC detected from 2003 to 2015 through the French national screening programme was included. All imaging findings were recorded. Statistical analyses were performed for the entire cohort (n = 450) and separately for the two groups (stage 0 n = 268, stage 1 n = 182). Factors associated with imaging surveillance, including the patient's referring gastroenterologist, were determined by logistic regression.

Results

A total of 450 patients were followed up for 6.6 ± 3.9 years. Imaging surveillance was performed for 159 (35.3%), more often for those with stage 1 (66.5%) than stage 0 (14.2%) tumours (p < 0.0001). Within the stage 1 group, 17 of the 47 patients (36.2%) treated by local (endoscopic or surgical transanal) resection alone were followed up by imaging monitoring. Factors significantly associated with surveillance in the entire cohort were the gastroenterologist assigned to the patient (p < 0.0001) and surgical vs endoscopic resection (OR = 39.0, p < 0.0001). The histological risk of lymph node metastasis was not significantly associated with imaging monitoring for stage 1 patients. Of the 5 patients who developed distant metastasis during follow-up, one was diagnosed through imaging surveillance.

Conclusion

This study demonstrates excessive imaging surveillance for early-stage cancers. The use of surgical over endoscopic tumour resection could promote unnecessary surveillance.

Il testo completo di questo articolo è disponibile in PDF.

Abbreviations : CRC, CT, US, IMC, UICC, OR, CI, 18-FDG PET

Keywords : Early-stage colorectal cancer, Endoscopic therapy, Surgical treatment, Colorectal cancer screening, Imaging surveillance


Mappa


© 2021  Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 45 - N° 6

Articolo 101735- Novembre 2021 Ritorno al numero
Articolo precedente Articolo precedente
  • A guide for assessing the clinical relevance of findings in small bowel capsule endoscopy: analysis of 8064 answers of international experts to an illustrated script questionnaire
  • R. Leenhardt, A. Koulaouzidis, D. McNamara, M. Keuchel, R. Sidhu, M.E. McAlindon, J.C. Saurin, R. Eliakim, I. Fernandez-Urien Sainz, J.N. Plevris, G. Rahmi, E. Rondonotti, B. Rosa, C. Spada, E. Toth, C. Houdeville, C. Li, M. Robaszkiewicz, P. Marteau, X. Dray
| Articolo seguente Articolo seguente
  • TSHZ3 functions as a tumor suppressor by DNA methylation in colorectal cancer
  • Youxin Zhou, Sentai Wang, Xuequn Yin, Guanzhuang Gao, Qiang Wang, Qiaoming Zhi, Ye Han, Yuting Kuang

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2025 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.